Involvement of phosphodiesterase-cGMP-PKG pathway in intracellular Ca2+ oscillations in pituitary GH3 cells

Biochim Biophys Acta. 1999 Mar 8;1449(2):186-93. doi: 10.1016/s0167-4889(99)00013-0.

Abstract

The present study investigates the potential role of the Ca2+-calmodulin-dependent type I phosphodiesterase (PDE)-cGMP-protein kinase G (PKG) pathway in spontaneous [Ca2+]i oscillations in GH3 cells using fura-2 single cell videoimaging. Vinpocetine (2.5-50 microM), a selective inhibitor of type I PDE, induced a concentration-dependent inhibition of spontaneous [Ca2+]i oscillations in these pituitary cells, and at the same time produced an increase of the intracellular cGMP content. The cell permeable cGMP analog N2,2'-O-dibutyryl-cGMP (dB-cGMP) (1 mM) caused a progressive reduction of the frequency and the amplitude of spontaneous [Ca2+]i oscillations when added to the medium. KT5823 (400 nM), a selective inhibitor of cGMP-dependent protein kinase (PKG), produced an increase of baseline [Ca2+]i and the disappearance of spontaneous [Ca2+]i oscillations. When KT5823 was added before vinpocetine, the PKG inhibitor counteracted the [Ca2+]i lowering effect of the cGMP catabolism inhibitor. Finally, the removal of extracellular Ca2+ or the blockade of L-type voltage-sensitive calcium channels (VSCC) by nimodipine produced a decrease of cytosolic cGMP levels. Collectively, the results of the present study suggest that spontaneous [Ca2+]i oscillations in GH3 cells may be regulated by the activity of type I PDE-cGMP-PKG pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology
  • Animals
  • Calcium / metabolism
  • Carbazoles*
  • Cell Line
  • Cyclic AMP / metabolism
  • Cyclic GMP / metabolism*
  • Cyclic GMP-Dependent Protein Kinases
  • Cyclic Nucleotide Phosphodiesterases, Type 1
  • Dibutyryl Cyclic GMP / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Indoles / pharmacology
  • Phosphoric Diester Hydrolases / metabolism*
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism*
  • Protein Kinases / metabolism*
  • Pyrroles / pharmacology
  • Vinca Alkaloids / pharmacology

Substances

  • Alkaloids
  • Carbazoles
  • Enzyme Inhibitors
  • Indoles
  • Pyrroles
  • Vinca Alkaloids
  • KT 5823
  • Dibutyryl Cyclic GMP
  • vinpocetine
  • KT 5720
  • Cyclic AMP
  • Protein Kinases
  • Cyclic GMP-Dependent Protein Kinases
  • Phosphoric Diester Hydrolases
  • Cyclic Nucleotide Phosphodiesterases, Type 1
  • Cyclic GMP
  • Calcium